Engineering SHP2 Phosphatase for Optical Control.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
06 12 2022
Historique:
pubmed: 9 11 2022
medline: 22 12 2022
entrez: 8 11 2022
Statut: ppublish

Résumé

Signal transduction pathways are responsible for maintaining cellular functions, including proliferation, differentiation, apoptosis, and cell cycle progression. These pathways are maintained through the propagation of phosphorylation signals by protein kinases, as well as the removal of phosphorylation signals by protein phosphatases. Depending on the context, post-translational modification could have either a positive or negative effect on a signaling pathway. Intricate networks of positive and negative regulators offer a challenging target for the dissection of cell signaling mechanisms, particularly regarding the more subtle dampening of signal transduction through phosphatases. We report the development of two complimentary methods for the optical control of a complex phosphatase: SH2 domain-containing protein tyrosine phosphatase-2 (SHP2). We investigated controlling the catalytic function of SHP2 through (1) site-specific incorporation of a caged tyrosine for light activation of catalytic activity for the control of an essential substrate binding residue and (2) site-specific incorporation of a caged lysine at a conserved residue within an allosteric pocket for the control of SHP2 binding partner docking sites. These methods are generalizable to proteins bearing either a protein tyrosine phosphatase (PTP) catalytic domain or an SH2 domain, including SHP1, PTP family phosphatases, and a diverse range of SH2 domain-containing proteins.

Identifiants

pubmed: 36346979
doi: 10.1021/acs.biochem.2c00387
doi:

Substances chimiques

Protein Tyrosine Phosphatase, Non-Receptor Type 11 EC 3.1.3.48
SH2 Domain-Containing Protein Tyrosine Phosphatases EC 3.1.3.48

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2687-2697

Auteurs

Amy Ryan (A)

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Chasity P Janosko (CP)

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Taylor M Courtney (TM)

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Alexander Deiters (A)

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin

Classifications MeSH